Novo Nordisk shares have fallen nearly 50 percent in six months. Buying them on sale may still make sense

As recently as March, Denmark's Novo Nordisk was the most valuable European company traded on the stock exchange. Since then, however, the company's shares have been practically losing ground. In the last week alone, the value of Novo Nordisk's securities has decreased by almost 10 percent. The European pharmaceutical giant has been...